Notice: Some of the studies in this table were not included in the odds-ratio analysis due to heterogeneity and bias assessment problems [110–117].

However, they were included in other analyses. YOP: year of publish, HIV: human immunodeficiency virus, PCP: pneumocystosis, HAP: HIV-associated pneumocystis, -: negative, +: positive, LDH: lactate dehydrogenase, BDG: β-D-glucan, ART: antiretroviral therapy, PFX: prophylaxis, QA: quality assessment, ND: not defined, L: low, M: moderate, H: high.